Galantos Pharma

Recent Finacing

Series C

Recent Raise

$5.7M

Galantos Pharma is a Germany-based biotech developing neuroprotective therapeutics for Alzheimer's disease, advancing lead compound Memogain® toward clinical trials and developing additional AD candidates.

Founded 2005

Rheinland-Pfalz, Germany

1-10

Private

galantos.com

Highlights

Focus Areas

Biopharma

Biotechnology

Health Care

Pharmaceutical

Recent Investors

Financials

$5.7M

Total Raised

1

Funding round

6

Investors